Vital Farms VITL · NASDAQ
$9.34 -1.37% (-$0.13)
Summary
47 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 268% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Out of every 100 USD of revenue, only 0.0 USD is left as net profit.
- Operating profit covers the interest on its debt only 1.7 times.
- It earns only 0.0 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Agricultural Farm Products)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2,565.4 USD for 1 USD of yearly profit. Over the last five years it was 185.4 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 29% a year over 5 years. Over the last 3 years it grew by 28% a year. For the next fiscal year analysts expect revenue to grow by 2.2%. Earnings per share grew by 268% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 72 USD
- Sales and administration 28 USD
- Taxes and other 0.0 USD
- Net profit 0.0 USD
Net profit, industry median (Agricultural Farm Products) 22 USD
Out of every 100 USD of revenue, 0.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 7
- Sell 0
Today's price within the analysts' price targets
The average target of $13.11 is 40% above today's price. 56% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Eggs And Egg Related Products 97%
- Butter And Butter Related Products 3.5%
By region
The company reports no revenue by region.
Eggs And Egg Related Products brings in 97% of revenue.
Segments in detail